Immunologic targeting of genitourinary malignancies.

被引：0
|
作者：
Vieweg, JW [1 ]
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：191S / 191S
页数：1
相关论文
共 50 条
  • [1] Targeting Axl Kinase in Hematological Malignancies.
    Gourley, Eric S.
    Liu, Xiao-hui
    Hewitt, William
    Walker, Rusty
    Warner, Steven L.
    Vankayalapati, Hariprasad
    Bearss, David J.
    BLOOD, 2009, 114 (22) : 1078 - 1078
  • [2] Assessing the impact of the COVID-19 pandemic on patients with genitourinary malignancies.
    Borno, Hala
    Zhang, Sylvia
    Gomez, Scarlett Lin
    Kaplan, Celia
    Miaskowski, Christine
    Hong, Julian
    Idossa, Dame
    Bailey, Adina
    Small, Eric Jay
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [3] Cost savings associated with palliative care among patients with genitourinary malignancies.
    Chansriwong, Phichai
    Thokanit, Nintita Sripaibookij
    Semsarn, Siriporn
    Utthiya, Pinyo
    Kasemsup, Vijj
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
  • [4] Targeting the Tumor Microenvironment with Immunotherapy for Genitourinary Malignancies
    Marciscano, Ariel E.
    Madan, Ravi A.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2018, 19 (03)
  • [5] Targeting the Tumor Microenvironment with Immunotherapy for Genitourinary Malignancies
    Ariel E. Marciscano
    Ravi A. Madan
    Current Treatment Options in Oncology, 2018, 19
  • [6] Fragmentomics of cell-free DNA from targeted panels in genitourinary malignancies.
    Taylor, Amy K.
    Helzer, Kyle
    Sharifi, Marina Nasrin
    Sperger, Jamie M.
    Shi, Yue
    Annala, Matti
    Reese, Shannon
    Kaufmann, Katherine
    Schehr, Jennifer L.
    Sethakorn, Nan
    Kosoff, David
    Kyriakopoulos, Christos
    Armstrong, Andrew J.
    McKay, Rana R.
    Feng, Felix Y.
    Wisinski, Kari Braun
    Emamekhoo, Hamid
    Wyatt, Alexander William
    Lang, Joshua Michael
    Zhao, Shuang
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 199 - 199
  • [7] Detecting and targeting cellular heterogeneity of the lymphoid blood malignancies.
    Wu, Catherine J.
    CANCER RESEARCH, 2020, 80 (21)
  • [8] Screen failure rates in contemporary phase II/III therapeutic trials in genitourinary malignancies.
    Wong, Sarah E.
    North, Scott A.
    Sweeney, Christopher
    Stockler, Martin R.
    Sridhar, Srikala S.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [9] Distribution of immune-related adverse events (irAEs) across genitourinary (GU) malignancies.
    Mar, Nataliya
    Slaught, Matthew
    Kaakour, Dalia
    Azizi, Armon
    Valerin, Jennifer Brooke
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [10] A novel treatment strategy targeting shugoshin 1 in hematological malignancies.
    Ikezoe, Takayuki
    Yang, Jing
    Nishioka, Chie
    Yokoyama, Akihito
    CANCER RESEARCH, 2013, 73 (08)
12345